Creative Planning’s Marker Therapeutics MRKR Stock Holding History

Creative Planning’s Portfolio MRKR Stock Details MRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.4K	Hold	17,312	–	–	﹤0.01%	4177
2026 Q1	$22.5K	Hold	17,312	–	–	﹤0.01%	4044
2025 Q4	$25.8K	Hold	17,312	–	–	﹤0.01%	3837
2025 Q3	$15.5K	Hold	17,312	–	–	﹤0.01%	3826
2025 Q2	$26.5K	Hold	17,312	–	–	﹤0.01%	3577
2025 Q1	$21.3K	Hold	17,312	–	–	﹤0.01%	3400
2024 Q4	$53.8K	Hold	17,312	–	–	﹤0.01%	3239
2024 Q3	$48.8K	Hold	17,312	–	–	﹤0.01%	3100
2024 Q2	$94K	Hold	17,312	–	–	﹤0.01%	2847
2024 Q1	$74.4K	Hold	17,312	–	–	﹤0.01%	2749
2023 Q4	$95.2K	Hold	17,312	–	–	﹤0.01%	2576
2023 Q3	$78.6K	Hold	17,312	–	–	﹤0.01%	2422
2023 Q2	$53.7K	Sell	17,312 -250	-1%	-$435	﹤0.01%	2433
2023 Q1	$12.5K	Sell	17,562 -602	-3%	-$1.43K	﹤0.01%	2452
2022 Q4	$48.3K	Hold	18,164	–	–	﹤0.01%	2235
2022 Q3	$67K	Hold	18,164	–	–	﹤0.01%	2088
2022 Q2	$60K	Buy	18,164 +660	+4%	+$2.19K	﹤0.01%	2032
2022 Q1	$77K	Hold	17,504	–	–	﹤0.01%	2017
2021 Q4	$166K	Buy	17,504 +2,968	+20%	+$39.4K	﹤0.01%	1902
2021 Q3	$246K	Sell	14,536 -500	-3%	-$10.2K	﹤0.01%	1719
2021 Q2	$420K	Sell	15,036 -1,100	-7%	-$29K	﹤0.01%	1376
2021 Q1	$361K	Buy	+16,136	New	+$369K	﹤0.01%	1669
2020 Q2	–	Sell	-2,450	Closed	-$47K	–	2086
2020 Q1	$47K	Buy	+2,450	New	+$62.4K	﹤0.01%	1639

Other funds holding MRKR

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

Creative Planning's MRKR Position: Q2 2026 in Review

Creative Planning held its Marker Therapeutics (MRKR) position steady in Q2 2026 at 17,312 shares worth $25.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4177.

Creative Planning first reported a position in MRKR in Q1 2020 and has held it in 23 quarters since. The position peaked at $420K in Q2 2021. 35 funds tracked by Wall St. Rank hold MRKR as of Q2 2026.

Creative Planning held 17,312 shares of Marker Therapeutics worth $25.4K as of Q2 2026.
Creative Planning left its Marker Therapeutics share count unchanged in Q2 2026.
Marker Therapeutics made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4177 holding.
Creative Planning first reported a position in Marker Therapeutics in Q1 2020 and has held it in 23 quarters since.
Creative Planning's Marker Therapeutics position peaked at $420K in Q2 2021.
35 funds tracked by Wall St. Rank held Marker Therapeutics as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.